P3-086: Initial safety results from expended access program (EAP) with erlotinib in non small cell lung cancer (NSCLC) in Israel

Autor:	Ofer Merimsky, Dov Flex, Frida Barak, Haim Biran, Maya Gottfried, Arnoldo Cijon, Julia Dudnik, Nili Ramu, Mark Levit, Mirjiana Wollner
Rok vydání:	2007
Předmět:	Oncology Pulmonary and Respiratory Medicine medicine.medical_specialty business.industry non-small cell lung cancer (NSCLC) medicine.disease respiratory tract diseases Internal medicine medicine Erlotinib business neoplasms health care economics and organizations medicine.drug
Zdroj:	Journal of Thoracic Oncology. 2(8):S715-S716
ISSN:	1556-0864
DOI:	10.1097/01.jto.0000284062.18986.6b
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b492415645cb02c2239b55252ee3ab4d Zobrazit plný text záznamu